Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Knott

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Control of renal factors in plasma homovanillic acid measurementsF Amin, A E Stroe, T Kahn, et al.
Schizophrenia Bulletin|January 1, 1995
Assessment of the central dopaminergic index of plasma HVA in schizophreniaF Amin, M Davidson, R S Kahn, et al.
Biological Psychiatry|May 20, 1999
Genetic antecedents of dopamine dysfunction in schizophreniaF Amin, J M Silverman, L J Siever, et al.
Lancet (London, England)|May 29, 1971
Treatment of Parkinson's disease with amantadine and levodopa. A one-year studyJ D Parkes, R C Baxter, G Curzon, et al.
Biological Psychiatry|August 1, 1995
Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's diseaseB A Lawlor, L M Bierer, T M Ryan, et al.
Journal of Neurochemistry|February 1, 1995
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficitsL M Bierer, V Haroutunian, S Gabriel, et al.
Psychiatry Research|December 1, 1993
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptomsL M Bierer, P J Knott, J M Schmeidler, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 24, 1998
Control of renal factors in plasma homovanillic acid measurementsF Amin, A E Stroe, T Kahn, et al.
Schizophrenia Bulletin|January 1, 1995
Assessment of the central dopaminergic index of plasma HVA in schizophreniaF Amin, M Davidson, R S Kahn, et al.
Biological Psychiatry|May 20, 1999
Genetic antecedents of dopamine dysfunction in schizophreniaF Amin, J M Silverman, L J Siever, et al.
Lancet (London, England)|May 29, 1971
Treatment of Parkinson's disease with amantadine and levodopa. A one-year studyJ D Parkes, R C Baxter, G Curzon, et al.
Biological Psychiatry|August 1, 1995
Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's diseaseB A Lawlor, L M Bierer, T M Ryan, et al.
Journal of Neurochemistry|February 1, 1995
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficitsL M Bierer, V Haroutunian, S Gabriel, et al.
Psychiatry Research|December 1, 1993
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptomsL M Bierer, P J Knott, J M Schmeidler, et al.
Pageof 4